Presentation ACC 2024

Primary Results from the Phase 2 KARDIA-2 Study

Presenter: Akshay Desai

April 07, 2024

Clinical Cardiology

Clinical Pharma

Hypertension

Presentation

ACC 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation ACC 2024

Presenter: Gregg W Stone

April 07, 2024